AgelessRx review
Introductory offers with prepaid-plan conditions.
Longevity care, clearly compared
Understand the prices, plans and terms behind the promise. Compare online injection providers with the first payment, renewal and unanswered questions in view.
4 providers · 7 injection plans · Sources checked September 15, 2026

Start with the distinction
NAD+ is involved in cellular energy reactions. Sermorelin signals growth-hormone release. Both appear in the longevity market, but neither a mechanism nor a marketing label proves a longer life.
The price comparison
A first-month offer is not always the first bill. A weekly rate may require a year-long plan. Start with the source-backed facts below, then open a plan to inspect its terms.
4 sourced injection plans · USD · Alphabetical provider order, not a clinical ranking
| Provider / product | Advertised rate | Initial plan payment | Renewal evidence |
|---|---|---|---|
| AgelessRxNAD+ Injection Rx | $79.00first month; prepaid plan required | Not verified3-month plan billed in full | Published $149/mo after introductory first month; actual charge schedule must be checked at enrollment |
| EmbodyCompounded NAD+ Injections | $99.00per advertised month; promotional offer | Not verifiedCheckout period not verified | Page promises fixed $99/month pricing; checkout charge cycle and contract renewal terms still unverified |
| Luvo HealthNAD+ Injection | $27.00per week headline; annual term | $199.004-week term | Subscription renews; actual timing and renewal price disclosed at enrollment/account |
| Pallas HealthNAD+ injection | $199.00advertised monthly average | $597.0012-week term | $597.00Every 84 days |
Initial plan payment is the published treatment-term amount, not necessarily a charge at intake. Required extra fees and exact supplied quantities are not fully verified. No row establishes an equivalent dose, duration or result.
Two focused buying guides
Learn what the product is, compare the actual costs, then assess a provider. No catch-all anti-aging leaderboard.
Four providers, with promotions and recurring bills kept separate.
Three provider options, including the commitment behind the weekly rate.
The provider reviews
We read the product pages and the terms together. These are public-source reviews, not hands-on medication tests or clinical endorsements. Every review shows its sources and the details that still need confirmation.
No active affiliate links at launchIntroductory offers with prepaid-plan conditions.
NAD+ offer with billing details still to confirm.
A shorter entry term; watch the annual headline.
A published twelve-week bill and renewal.
Evidence before promises
It describes our subject, not a guaranteed treatment benefit. Compounded drugs are not FDA-approved, and their risks deserve the same attention as their prices. Longevity Ranked helps you compare public information; individual medical decisions belong with a clinician.
FDA: understanding compounded-drug risksRead the evidence guides